Literature DB >> 12116026

Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2.

Hiroshi Kimura1, Yoshinori Ito, Masahide Futamura, Yoshihiro Ando, Yumi Yabuta, Yo Hoshino, Yukihiro Nishiyama, Tsuneo Morishima.   

Abstract

Neonatal herpes simplex virus (HSV) infection is a severe disease with high mortality and morbidity in spite of the development of effective anti-viral therapies. The viral load in neonatal herpes simplex virus (HSV) infection was measured retrospectively in 37 patients. HSV DNA copy numbers in serum and cerebrospinal fluid (CSF) were quantified using a real-time PCR assay. Patients with disseminated infection had a higher viral load in their sera. whereas patients with central nervous system (CNS) infection exhibited a higher viral load in the CSF. The viral load was significantly higher in the serum of patients who died later. Interestingly, patients with HSV type-2 infection exhibited more CNS involvement and neurological impairment, together with a high viral load in the CSF, than did HSV type-1 patients. These results suggest that quantitation of HSV viral load may be useful for assessing the prognosis, and may provide additional information for the management of neonatal HSV infection. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116026     DOI: 10.1002/jmv.10084

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

1.  Rapid detection of herpes simplex virus DNA in cerebrospinal fluid: comparison between loop-mediated isothermal amplification and real-time PCR.

Authors:  Hiroshi Kimura; Masaru Ihira; Yoshihiro Enomoto; Jun-ichi Kawada; Yoshinori Ito; Tsuneo Morishima; Tetsushi Yoshikawa; Yoshizo Asano
Journal:  Med Microbiol Immunol       Date:  2005-05-21       Impact factor: 3.402

Review 2.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Prevention and management of neonatal herpes simplex virus infections.

Authors:  Upton D Allen; Joan L Robinson
Journal:  Paediatr Child Health       Date:  2014-04       Impact factor: 2.253

Review 4.  Neonatal herpes simplex virus infections: where are we now?

Authors:  Clara Thompson; Richard Whitley
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 5.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection.

Authors:  Ann J Melvin; Kathleen M Mohan; Joshua T Schiffer; Linda M Drolette; Amalia Magaret; Lawrence Corey; Anna Wald
Journal:  J Pediatr       Date:  2014-12-06       Impact factor: 4.406

Review 7.  Laboratory Diagnosis of Neonatal Herpes Simplex Virus Infections.

Authors:  William J Muller; Xiaotian Zheng
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

8.  Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.

Authors:  David W Kimberlin; Jill Baley
Journal:  Pediatrics       Date:  2013-01-28       Impact factor: 7.124

9.  Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: development and methodology.

Authors:  Teruyuki Takahashi; Masato Tamura; Yukihiro Asami; Eiko Kitamura; Kosuke Saito; Tsukasa Suzuki; Sachiko Nonaka Takahashi; Koichi Matsumoto; Shigemasa Sawada; Eise Yokoyama; Toshiaki Takasu
Journal:  J Clin Microbiol       Date:  2008-03-12       Impact factor: 5.948

10.  Novel technique of quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA.

Authors:  Teruyuki Takahashi; Tomohiro Nakayama
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.